This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
protein
product name :
Recombinant Human IGFBP-4 Protein, CF
catalog :
804-GB
quantity :
25 ug
price :
329 USD
citations: 7
Reference |
---|
Wirthgen E, Goumon S, Kunze M, Walz C, Spitschak M, Tuchscherer A, et al. Effects of Transport Duration and Environmental Conditions in Winter or Summer on the Concentrations of Insulin-Like Growth Factors and Insulin-Like Growth Factor-Binding Proteins in the Plasma of Market-Weight Pigs. Front Endocrinol (Lausanne). 2018;9:36 pubmed publisher
|
Wang T, Chang C, Wu H, Chiu Y, Chen C, Wang H. Insulin-like growth factor-II (IGF-II), IGF-binding protein-3 (IGFBP-3), and IGFBP-4 in follicular fluid are associated with oocyte maturation and embryo development. Fertil Steril. 2006;86:1392-401 pubmed
|
Cortesio C, Jiang W. Mannan-binding lectin-associated serine protease 3 cleaves synthetic peptides and insulin-like growth factor-binding protein 5. Arch Biochem Biophys. 2006;449:164-70 pubmed
|
Wunder D, Mueller M, Birkhäuser M, Bersinger N. Steroids and protein markers in the follicular fluid as indicators of oocyte quality in patients with and without endometriosis. J Assist Reprod Genet. 2005;22:257-64 pubmed
|
Nakamura M, Miyamoto S, Maeda H, Ishii G, Hasebe T, Chiba T, et al. Matrix metalloproteinase-7 degrades all insulin-like growth factor binding proteins and facilitates insulin-like growth factor bioavailability. Biochem Biophys Res Commun. 2005;333:1011-6 pubmed
|
product information
brand :
R&D Systems
master code :
804-GB
SKU :
804-GB-025
product name :
Recombinant Human IGFBP-4 Protein, CF
description :
The Recombinant Human IGFBP-4 Protein, CF from R&D Systems is derived from NS0. The Recombinant Human IGFBP-4 Protein, CF has been validated for the following applications: Bioactivity.
target :
IGFBP-4
category :
Proteins and Enzymes
unit size :
25 ug
buffer :
Lyophilized from a 0.2 µm filtered solution in PBS.
conjugate :
Unconjugated
purity :
>97%, by SDS-PAGE under reducing conditions and visualized by silver stain
species :
Human
observed molecular weight :
32 kDa, reducing conditions
theoretical molecular weight :
26 kDa
gene symbol :
IGFBP4
details of functionality :
Measured by its ability to inhibit the biological activity of IGF-I or IGF-II on MCF-7 human breast cancer cells. Karey, K.P. et al . (1988) Cancer Research 48 :4083. The ED50 for this effect is 0.03-0.09 µg/mL in the presence of 14 ng/mL recombinant human IGF-II.
endotoxin note :
<0.01 EU per 1 µg of the protein by the LAL method.
catalog number base :
804-GB
accessionNumbers :
AAA62670
applications :
Bioactivity
source :
Mouse myeloma cell line, NS0-derived human IGFBP-4 protein Asp22-Glu258, with an N-terminal Met
2020 USD :
329
2021 USD :
329 USD
alt names :
BP-4, HT29-IGFBP, IBP4insulin-like growth factor-binding protein 4, IGF-binding protein 4, IGFBP4, IGFBP-4IBP-4, insulin-like growth factor binding protein 4
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.
company information

R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.
questions and comments